Protocol for a Safety, Feasibility, and Dose-Finding Study of the Hemopurifier Device in Patients with Solid Tumors Who Have Stable or Progressive Disease During Pembrolizumab or Nivolumab Monotherapy
medrxiv(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined